about
Consequences of repeated blood-brain barrier disruption in football playersExtracranial sources of S100B do not affect serum levelsPathophysiological impact of cigarette smoke exposure on the cerebrovascular system with a focus on the blood-brain barrier: expanding the awareness of smoking toxicity in an underappreciated areaPathobiology of tobacco smoking and neurovascular disorders: untied strings and alternative productsSerum S100B: a potential biomarker for suicidality in adolescents?Serum S100B levels after meningioma surgery: A comparison of two laboratory assays.A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patientsBiochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus reportIs peripheral immunity regulated by blood-brain barrier permeability changes?WONOEP appraisal: Molecular and cellular biomarkers for epilepsy.S100B Serum Levels in Schizophrenia Are Presumably Related to Visceral Obesity and Insulin ResistanceSeizure-promoting effect of blood-brain barrier disruption.Validating serum S100B and neuron-specific enolase as biomarkers for the human brain - a combined serum, gene expression and MRI study.Reliable disease biomarkers characterizing and identifying electrohypersensitivity and multiple chemical sensitivity as two etiopathogenic aspects of a unique pathological disorder.Circulating brain microvascular endothelial cells (cBMECs) as potential biomarkers of the blood-brain barrier disorders caused by microbial and non-microbial factors.Distinct patterns of cerebral extravasation by Evans blue and sodium fluorescein in ratsSignificance of ubiquitin carboxy-terminal hydrolase L1 elevations in athletes after sub-concussive head hitsUmbilical cord blood biomarkers of neurologic injury and the risk of cerebral palsy or infant deathTrajectory analysis of serum biomarker concentrations facilitates outcome prediction after pediatric traumatic and hypoxemic brain injuryS100β as a novel and accessible indicator for the presence of monocyte-driven encephalitis in AIDSEffects of Single Low Dose of Dexamethasone before Noncardiac and Nonneurologic Surgery and General Anesthesia on Postoperative Cognitive Dysfunction-A Phase III Double Blind, Randomized Clinical TrialAn examination of the blood-brain barrier in health and disease.Proteomic identification of biomarkers of traumatic brain injury.Detection of brain injury by fatty acid-binding proteins.Changes in Astroglial Markers in a Maternal Immune Activation Model of Schizophrenia in Wistar Rats are Dependent on Sex.Serum Concentrations of S100B are not Affected by Cycling to Exhaustion With or Without Vibration.Biomarker evidence for mild central nervous system injury after surgically-induced circulation arrest.Does Systemic Inflammation Play a Role in Pediatric Psychosis?The Reference Level of Serum S-100B Protein for Poor Prognosis in Patients with Intracranial Extracerebral Hematoma.S100B and S100B autoantibody as biomarkers for early detection of brain metastases in lung cancer.Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis.Serum S100B represents a new biomarker for mood disorders.Molecular biomarkers in stroke diagnosis and prognosis.Serum S100B Levels and Major Depressive Disorder: Its Characteristics and Role in Antidepressant Response.Addressing the needs of traumatic brain injury with clinical proteomics.PG2 for patients with acute spontaneous intracerebral hemorrhage: a double-blind, randomized, placebo-controlled study.Mood disorders are glial disorders: evidence from in vivo studies.Dynamic action of neurometals at the synapse.S100B and schizophrenia.S100B as a marker for brain damage and blood-brain barrier disruption following exercise.
P2860
Q21133671-C860A99E-5D83-4C30-9B08-7A74C751D6C5Q22241536-B8CFFABE-615E-4BB3-B692-31C75495E3EAQ24627871-92DC1575-D229-4144-BA33-184DEF469DFFQ26777643-FFFD9BF3-5E8D-4BE4-B1DA-E9694654D8D7Q28751578-3FFD329C-F4C5-4911-BFC7-792EFDB5B822Q33370648-FF94C26C-9EBC-4962-AAB3-81B97FEE6315Q33474338-B832286A-9786-4D9D-9998-1926F66E5F88Q33721681-25081F5F-8D84-4B53-9517-8ED41A33B815Q33838466-ACA56CBD-B1DD-4287-A6FE-DE2AFFD1DE7FQ33915194-609B9B58-7B5E-43F4-8DE6-0C13C322D532Q33984573-3119A0AC-4BB9-4F05-B444-71EAD16A9346Q34056074-522F87DA-7905-4B92-9B83-0EFA39A2A20CQ34391480-5BBE9B0D-7D50-4AE8-B3AF-6A05E9BCA309Q34503321-35E65E7C-B954-4991-AB01-64F229CEB014Q34701013-537488B0-490B-4093-B1F8-42A3FCED425CQ34827819-64553457-5907-422C-83B1-8FB081F3A547Q35164692-D978DD6E-BD4B-4822-911A-4AA1BBDD2883Q35534268-A69125D9-543E-478D-BA14-D8B2347246E1Q35547437-92439604-4CE9-455F-A132-893A3987102BQ35603172-CD83452A-EB32-4635-B40A-F34FEA83B565Q36010475-536044C7-CD31-4B8C-87BE-36ACCB52EAC2Q36143960-ADBDE4E5-89C2-4D79-A1CB-DC5D765C0D73Q36227974-76EFC298-A3D7-4ED5-961A-15CB1F49CAE0Q36275438-8934B518-9C9E-4CA5-9DDA-03CAC7D497BEQ36400712-E490FA9C-AF25-4AA6-AE38-83ABBE36D6B5Q36657804-B86B35B4-7085-4254-856F-41E477800177Q36807376-1670F598-16AF-46D5-9BDA-692ACE993B22Q36986370-517B85C0-A0CD-44DD-89B2-9147F93F1B3EQ37155382-BBE1D077-811F-4011-8937-0F7E26D2E58EQ37227291-6E0A7F49-602A-48A7-A547-F9936C2E6717Q37250446-9D879C51-FF0E-4F04-A1E1-2C75B667888EQ37290664-B4F99F41-234D-4693-903D-DA661D35DC29Q37408830-0D8BA828-2CBD-4AA8-B16F-0F8748281035Q37483986-69116FD6-04E0-45B1-8866-2D1270E71A01Q37685775-A8B1F18A-59EF-4B39-B2D4-43686A727376Q37731512-2C96375E-7E23-43F5-83E6-739DE4CD7A97Q37768341-ABB09F33-489E-496A-B8FF-90FD45D9CE22Q37853424-340A2640-ED02-4653-8D64-259A438A005BQ38084359-13B0E265-2EFB-4C56-AE8B-7B1800574428Q38160208-15C4AF89-3C93-4299-9D24-70A9C689F5FA
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Peripheral markers of blood-brain barrier damage.
@ast
Peripheral markers of blood-brain barrier damage.
@en
Peripheral markers of blood-brain barrier damage.
@nl
type
label
Peripheral markers of blood-brain barrier damage.
@ast
Peripheral markers of blood-brain barrier damage.
@en
Peripheral markers of blood-brain barrier damage.
@nl
prefLabel
Peripheral markers of blood-brain barrier damage.
@ast
Peripheral markers of blood-brain barrier damage.
@en
Peripheral markers of blood-brain barrier damage.
@nl
P2093
P50
P1433
P1476
Peripheral markers of blood-brain barrier damage
@en
P2093
Kerri Hallene
Sunil Bhudia
Vincent Fazio
P356
10.1016/J.CCCN.2003.12.008
P577
2004-04-01T00:00:00Z